Uzi Gafter

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

Mona Boaz, Shmuel Smetana, Talia Weinstein et al. · The Lancet · 2000 · 1K citations

Medicine, Nephrology, Dialysis +13

Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy

Michal Herman‐Edelstein, Pnina Scherzer, Ana Tobar et al. · Journal of Lipid Research · 2013 · 635 citations · Full text

Medicine, Biochemistry, Nephrology +17

Glomerular hemodynamics in severe obesity

Avry Chagnac, Talia Weinstein, Asher Korzets et al. · American Journal of Physiology-Renal Physiology · 2000 · 607 citations

Medicine, Endocrinology, Physiology +15

The Effects of Weight Loss on Renal Function in Patients with Severe Obesity

Avry Chagnac, T Weinstein, Michal Herman et al. · Journal of the American Society of Nephrology · 2003 · 535 citations

Medicine, Nephrology, Physiology +17

Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease

Inbar Zucker, Gil Yosipovitch, Michael David et al. · Journal of the American Academy of Dermatology · 2003 · 258 citations

Medicine, Internal Medicine, Nephrology +15